View the current altRx GLP-1 offer (official altRx page) What's Changing for Compounded GLP-1 Programs in 2026 Anyone evaluating altRx in 2026 should understand the regulatory backdrop, because the rules around compounded GLP-1 medications have shifted significantly over the past 18 months and are continuing to evolve
Clear triggers for contact ensure timely intervention to preserve safety and therapeutic benefit
Alternative topical treatments may be a good fit if you: Want to reduce or avoid long-term steroid use Are treating sensitive areas like the face, eyelids, or skin folds Feel stuck in the apply improve flare cycle Need a long-term maintenance strategy rather than short-term suppression Have eczema that flares in oily areas (like the scalp or around the nose) Have tried conventional treatments but havent found lasting relief Many of the families I work with simply want a more thoughtful, root-cause approach not just another prescription
The "selectivity" claim for ipamorelin refers specifically to reduced stimulation of cortisol, ACTH, and prolactin compared to earlier GHRP compounds
To achieve the best results, it is essential to accompany its use with a nutritious diet and constant physical activity
2015-2026 (MFW)